tiprankstipranks
Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
US Market

Compare Arcturus Therapeutics (ARCT) vs. Competitors

2,170 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Arcturus Therapeutics
$8.03
$228.24M
-1.44
-21.27%
7 Buy
3 Hold
0 Sell
Moderate Buy
Rigel
$27.53
$508.57M
2.10
51.18%
2 Buy
2 Hold
0 Sell
Moderate Buy
Arvinas Holding Company
$10.85
$693.98M
-9.53
51.11%
8 Buy
6 Hold
0 Sell
Moderate Buy
Compass Therapeutics
$5.45
$981.48M
-12.74
222.49%
9 Buy
0 Hold
0 Sell
Strong Buy
Olema Pharmaceuticals
$15.06
$1.32B
352.25%
11 Buy
1 Hold
0 Sell
Strong Buy
Erasca
$17.81
$5.54B
-8.47
1313.49%
8 Buy
1 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ARCT
Arcturus Therapeutics
8.03
-1.08
-11.86%
RIGL
Rigel
27.53
10.29
59.69%
ARVN
Arvinas Holding Company
10.85
4.29
65.40%
CMPX
Compass Therapeutics
5.45
3.99
273.29%
OLMA
Olema Pharmaceuticals
15.06
11.81
363.38%
ERAS
Erasca
17.81
16.65
1435.34%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts